Cargando…

Splicing factor ratio as an index of epithelial-mesenchymal transition and tumor aggressiveness in breast cancer

Epithelial-to-mesenchymal transition (EMT) has been shown to be associated with tumor progression and metastasis. During this process in breast cancer, a crucial role is played by alternative splicing systems. To identify a new early prognostic marker of metastasis, we evaluated EMT-related gene exp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fici, Pietro, Gallerani, Giulia, Morel, Anne-Pierre, Mercatali, Laura, Ibrahim, Toni, Scarpi, Emanuela, Amadori, Dino, Puisieux, Alain, Rigaud, Michel, Fabbri, Francesco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356812/ https://www.ncbi.nlm.nih.gov/pubmed/27911856 http://dx.doi.org/10.18632/oncotarget.13682

Ejemplares similares

Epithelial Mesenchymal Transition: a double-edged sword
por: Barriere, Guislaine, et al.
Publicado: (2015)

Circulating Tumor Cells: Back to the Future
por: Gallerani, Giulia, et al.
Publicado: (2017)

A new emergency in oncology: Bone metastases in breast cancer patients (Review)
por: IBRAHIM, TONI, et al.
Publicado: (2013)

RANK/RANK-L/OPG in Patients with Bone Metastases Treated with Anticancer Agents and Zoledronic Acid: A Prospective Study
por: Mercatali, Laura, et al.
Publicado: (2013)

Generation of Breast Cancer Stem Cells through Epithelial-Mesenchymal Transition
por: Morel, Anne-Pierre, et al.
Publicado: (2008)

Multiple Marker Detection in Peripheral Blood for NSCLC Diagnosis
por: Ulivi, Paola, et al.
Publicado: (2013)

Vitamin D receptor polymorphisms or serum levels as key drivers of breast cancer development? The question of the vitamin D pathway
por: Amadori, Dino, et al.
Publicado: (2017)

Elf5 inhibits epithelial mesenchymal transition in mammary gland development and breast cancer metastasis by transcriptionally repressing Snail2/Slug
por: Chakrabarti, Rumela, et al.
Publicado: (2012)

Inhibition of breast cancer cell proliferation in repeated and non-repeated treatment with zoledronic acid
por: Ibrahim, Toni, et al.
Publicado: (2012)

DNA ploidy and S-phase fraction analysis in peritoneal carcinomatosis from ovarian cancer: correlation with clinical pathological factors and response to chemotherapy
por: Carloni, Silvia, et al.
Publicado: (2017)

Peripheral Blood miR-328 Expression as a Potential Biomarker for the Early Diagnosis of NSCLC
por: Ulivi, Paola, et al.
Publicado: (2013)

Single-Cell NGS-Based Analysis of Copy Number Alterations Reveals New Insights in Circulating Tumor Cells Persistence in Early-Stage Breast Cancer
por: Rossi, Tania, et al.
Publicado: (2020)

Dissecting Molecular Heterogeneity of Circulating Tumor Cells (CTCs) from Metastatic Breast Cancer Patients through Copy Number Aberration (CNA) and Single Nucleotide Variant (SNV) Single Cell Analysis
por: Rossi, Tania, et al.
Publicado: (2022)

The Effect of Everolimus in an In Vitro Model of Triple Negative Breast Cancer and Osteoclasts
por: Mercatali, Laura, et al.
Publicado: (2016)

Prognostic role of aspartate aminotransferase-lymphocyte ratio index in patients with metastatic colorectal cancer: results from the randomized ITACa trial
por: Casadei Gardini, Andrea, et al.
Publicado: (2018)

EGFR methylation and outcome of patients with advanced colorectal cancer treated with cetuximab
por: CHIADINI, ELISA, et al.
Publicado: (2015)

Quantitative Fluorescence Determination of Long-Fragment DNA in Stool as a Marker for the Early Detection of Colorectal Cancer
por: Calistri, Daniele, et al.
Publicado: (2009)

CNA Profiling of Single CTCs in Locally Advanced Esophageal Cancer Patients during Therapy Highlights Unexplored Molecular Pathways
por: Gallerani, Giulia, et al.
Publicado: (2021)

Osteoblastic bone metastases from neuroendocrine tumor (NET) of unknown origin detected by (18)fluorocholine PET/CT and its comparison with (68)gallium-DOTATOC PET/CT: Case report and review of the literature
por: Bongiovanni, Alberto, et al.
Publicado: (2017)

Management and potentialities of primary cancer cultures in preclinical and translational studies
por: Miserocchi, Giacomo, et al.
Publicado: (2017)

Update on the role of trabectedin in the treatment of intractable soft tissue sarcomas
por: Recine, Federica, et al.
Publicado: (2017)

High expression of spliced X-Box Binding Protein 1 in lung tumors is associated with cancer aggressiveness and epithelial-to-mesenchymal transition
por: Tavernier, Quentin, et al.
Publicado: (2020)

Circulating Plasma Levels of miR-20b, miR-29b and miR-155 as Predictors of Bevacizumab Efficacy in Patients with Metastatic Colorectal Cancer
por: Ulivi, Paola, et al.
Publicado: (2018)

Metastatic neuroendocrine neoplasia treatments in patients over 70 years of age
por: Bongiovanni, Alberto, et al.
Publicado: (2018)

A biomimetic 3D model of hypoxia-driven cancer progression
por: Liverani, Chiara, et al.
Publicado: (2019)

Epithelial specific splicing regulator proteins as emerging oncogenes in aggressive prostate cancer
por: Advani, Rahul, et al.
Publicado: (2023)

Expression of the FGFR2 mesenchymal splicing variant in epithelial cells drives epithelial-mesenchymal transition
por: Ranieri, Danilo, et al.
Publicado: (2015)

Acidic Growth Conditions Promote Epithelial-to-Mesenchymal Transition to Select More Aggressive PDAC Cell Phenotypes In Vitro
por: Audero, Madelaine Magalì, et al.
Publicado: (2023)

Current classification, treatment options, and new perspectives in the management of adipocytic sarcomas
por: De Vita, Alessandro, et al.
Publicado: (2016)

First-line chemotherapy in patients with metastatic gastroenteropancreatic neuroendocrine carcinoma
por: Bongiovanni, Alberto, et al.
Publicado: (2015)

Tumor-Stroma Crosstalk in Bone Tissue: The Osteoclastogenic Potential of a Breast Cancer Cell Line in a Co-Culture System and the Role of EGFR Inhibition
por: Mercatali, Laura, et al.
Publicado: (2017)

Epithelial Mesenchymal Transition: A New Insight into the Detection of Circulating Tumor Cells
por: Barrière, Guislaine, et al.
Publicado: (2012)

Prognostic role of serum concentrations of high-sensitivity C-reactive protein in patients with metastatic colorectal cancer: results from the ITACa trial
por: Gardini, Andrea Casadei, et al.
Publicado: (2016)

Myxofibrosarcoma primary cultures: molecular and pharmacological profile
por: De Vita, Alessandro, et al.
Publicado: (2017)

Activity of Eribulin in a Primary Culture of Well-Differentiated/Dedifferentiated Adipocytic Sarcoma
por: De Vita, Alessandro, et al.
Publicado: (2016)

Lineage‐specific mechanisms and drivers of breast cancer chemoresistance revealed by 3D biomimetic culture
por: Liverani, Chiara, et al.
Publicado: (2021)

Peritoneal carcinomatosis from ovarian cancer: chemosensitivity test and tissue markers as predictors of response to chemotherapy
por: Arienti, Chiara, et al.
Publicado: (2011)

Targeting the Metabolic Reprogramming That Controls Epithelial-to-Mesenchymal Transition in Aggressive Tumors
por: Morandi, Andrea, et al.
Publicado: (2017)

Predictive Role of Telomerase Activity in the Clinical Outcome of Patients with Benign Lesions of the Uterine Cervix or CIN
por: Bravaccini, Sara, et al.
Publicado: (2012)

Circulating Tumor Cells in the Adenocarcinoma of the Esophagus
por: Gallerani, Giulia, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_n62f2ptmhhchm8fonv4ghp9g28